Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
3801
3802
3803
3804
3805
3806
3807
3808
3809
3810
3811
3812
3813
3814
3815
3816
3817
3818
3819
3820
3821
3822
3823
3824
3825
3826
3827
3828
3829
3830
3831
3832
3833
3834
3835
3836
3837
3838
3839
3840
3841
3842
3843
3844
3845
3846
3847
3848
3849
3850
3851
3852
3853
3854
3855
3856
3857
3858
3859
3860
3861
3862
3863
3864
3865
3866
3867
3868
3869
3870
3871
3872
3873
3874
3875
3876
3877
3878
3879
3880
3881
3882
3883
3884
3885
3886
3887
3888
3889
3890
3891
3892
3893
3894
3895
3896
3897
3898
3899
3900
3901
3902
3903
3904
3905
3906
3907
3908
3909
3910
3911
3912
3913
3914
3915
3916
3917
3918
3919
3920
3921
3922
3923
3924
3925
3926
3927
3928
3929
3930
3931
3932
3933
3934
3935
3936
3937
3938
3939
3940
3941
3942
3943
3944
3945
3946
3947
3948
3949
3950
3951
3952
3953
3954
3955
3956
3957
3958
3959
3960
3961
3962
3963
3964
3965
3966
3967
3968
3969
3970
3971
3972
3973
3974
3975
3976
3977
3978
3979
3980
3981
3982
3983
3984
3985
3986
3987
3988
3989
3990
3991
3992
3993
3994
3995
3996
3997
3998
3999
4000
| UnnamedSample_HQ_transcript/565|m.413 | UnnamedSample_HQ_transcript/565 | Coverage 0.865 too low. | a79fcba09938d3d5b866ac5da1eae323 | 2155 | Pfam | PF18296 | MID domain of medPIWI | 1480 | 1756 | 6.5E-71 | T | 22-09-2020 | IPR041285 | MID domain of medPIWI |
| UnnamedSample_HQ_transcript/565|m.413 | UnnamedSample_HQ_transcript/565 | Coverage 0.865 too low. | a79fcba09938d3d5b866ac5da1eae323 | 2155 | Pfam | PF06333 | Mediator complex subunit 13 C-terminal domain | 1794 | 2154 | 3.4E-81 | T | 22-09-2020 | IPR009401 | Mediator complex subunit Med13, C-terminal |
| UnnamedSample_HQ_transcript/71421|m.18191 | UnnamedSample_HQ_transcript/71421 | Coverage 0.966 too low. | 1216e4c5f13e636d076f976b163c8c26 | 500 | Pfam | PF02171 | Piwi domain | 155 | 460 | 3.7E-86 | T | 22-09-2020 | IPR003165 | Piwi domain |
| UnnamedSample_HQ_transcript/30532|m.9591 | UnnamedSample_HQ_transcript/30532 | Coverage 0.178 too low. | 79dffe3dce2e26bfd4f17180d9d3ed01 | 616 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 304 | 568 | 9.3E-97 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/83552|m.20272 | UnnamedSample_HQ_transcript/83552 | Coverage 0.921 too low. | 1c9732445fb468ccb69779f7b2ba4760 | 218 | Pfam | PF13632 | Glycosyl transferase family group 2 | 3 | 143 | 9.0E-23 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/77917|m.19361 | UnnamedSample_HQ_transcript/77917 | Coverage 0.890 too low. | 1c9732445fb468ccb69779f7b2ba4760 | 218 | Pfam | PF13632 | Glycosyl transferase family group 2 | 3 | 143 | 9.0E-23 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/91404|m.21457 | UnnamedSample_HQ_transcript/91404 | Coverage 0.899 too low. | 920185d6d2c7ac4a8ee4c03ed68dae61 | 244 | Pfam | PF07850 | Renin receptor-like protein | 156 | 243 | 2.8E-30 | T | 22-09-2020 | IPR012493 | Renin receptor-like |
| UnnamedSample_HQ_transcript/81307|m.19936 | UnnamedSample_HQ_transcript/81307 | Coverage 0.704 too low. | b08fd9431a7c80a1037a03b0c94e20e8 | 394 | Pfam | PF07690 | Major Facilitator Superfamily | 97 | 281 | 6.1E-24 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/53859|m.14815 | UnnamedSample_HQ_transcript/53859 | Coverage 0.930 too low. | 8f3e34e8abbacf4812573aeab1f23894 | 542 | Pfam | PF00135 | Carboxylesterase family | 21 | 536 | 3.3E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/4618|m.2044 | UnnamedSample_HQ_transcript/4618 | Identity 0.872 too low. | 4c05d7dceb29d5a0e77ad92fac26a4c7 | 1486 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 1165 | 1258 | 6.3E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/4618|m.2044 | UnnamedSample_HQ_transcript/4618 | Identity 0.872 too low. | 4c05d7dceb29d5a0e77ad92fac26a4c7 | 1486 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 411 | 474 | 3.8E-16 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/4618|m.2044 | UnnamedSample_HQ_transcript/4618 | Identity 0.872 too low. | 4c05d7dceb29d5a0e77ad92fac26a4c7 | 1486 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 294 | 366 | 4.6E-9 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/4618|m.2044 | UnnamedSample_HQ_transcript/4618 | Identity 0.872 too low. | 4c05d7dceb29d5a0e77ad92fac26a4c7 | 1486 | Pfam | PF00271 | Helicase conserved C-terminal domain | 823 | 935 | 1.1E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/4618|m.2044 | UnnamedSample_HQ_transcript/4618 | Identity 0.872 too low. | 4c05d7dceb29d5a0e77ad92fac26a4c7 | 1486 | Pfam | PF00176 | SNF2 family N-terminal domain | 529 | 796 | 1.7E-62 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/31840|m.9907 | UnnamedSample_HQ_transcript/31840 | Coverage 0.451 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 444 | 465 | 2.3E-11 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/31840|m.9907 | UnnamedSample_HQ_transcript/31840 | Coverage 0.451 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 575 | 594 | 9.7E-10 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/31840|m.9907 | UnnamedSample_HQ_transcript/31840 | Coverage 0.451 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 493 | 514 | 2.0E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/31840|m.9907 | UnnamedSample_HQ_transcript/31840 | Coverage 0.451 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13176 | Tetratricopeptide repeat | 65 | 97 | 1.5E-5 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/31840|m.9907 | UnnamedSample_HQ_transcript/31840 | Coverage 0.451 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13424 | Tetratricopeptide repeat | 103 | 158 | 2.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/31840|m.9907 | UnnamedSample_HQ_transcript/31840 | Coverage 0.451 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13424 | Tetratricopeptide repeat | 207 | 273 | 3.3E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/39734|m.11796 | UnnamedSample_HQ_transcript/39734 | Coverage 0.492 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 444 | 465 | 2.3E-11 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/39734|m.11796 | UnnamedSample_HQ_transcript/39734 | Coverage 0.492 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 575 | 594 | 9.7E-10 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/39734|m.11796 | UnnamedSample_HQ_transcript/39734 | Coverage 0.492 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 493 | 514 | 2.0E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/39734|m.11796 | UnnamedSample_HQ_transcript/39734 | Coverage 0.492 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13176 | Tetratricopeptide repeat | 65 | 97 | 1.5E-5 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/39734|m.11796 | UnnamedSample_HQ_transcript/39734 | Coverage 0.492 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13424 | Tetratricopeptide repeat | 103 | 158 | 2.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/39734|m.11796 | UnnamedSample_HQ_transcript/39734 | Coverage 0.492 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13424 | Tetratricopeptide repeat | 207 | 273 | 3.3E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/36885|m.11139 | UnnamedSample_HQ_transcript/36885 | Coverage 0.474 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 444 | 465 | 2.3E-11 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/36885|m.11139 | UnnamedSample_HQ_transcript/36885 | Coverage 0.474 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 575 | 594 | 9.7E-10 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/36885|m.11139 | UnnamedSample_HQ_transcript/36885 | Coverage 0.474 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF02188 | GoLoco motif | 493 | 514 | 2.0E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/36885|m.11139 | UnnamedSample_HQ_transcript/36885 | Coverage 0.474 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13176 | Tetratricopeptide repeat | 65 | 97 | 1.5E-5 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/36885|m.11139 | UnnamedSample_HQ_transcript/36885 | Coverage 0.474 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13424 | Tetratricopeptide repeat | 103 | 158 | 2.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/36885|m.11139 | UnnamedSample_HQ_transcript/36885 | Coverage 0.474 too low. | eafe519323aabc59e8b1bf097a6b379d | 598 | Pfam | PF13424 | Tetratricopeptide repeat | 207 | 273 | 3.3E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/37522|m.11282 | UnnamedSample_HQ_transcript/37522 | Coverage 0.035 too low. | 0c20c3c3cb0c2f99395a0d94a9d8200b | 656 | Pfam | PF10551 | MULE transposase domain | 282 | 373 | 2.0E-6 | T | 22-09-2020 | IPR018289 | MULE transposase domain |
| UnnamedSample_HQ_transcript/21263|m.7222 | UnnamedSample_HQ_transcript/21263 | Coverage 0.169 too low. | 5991bceecc0964cd68d0d51608eaf5fa | 207 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 61 | 175 | 3.2E-25 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/5594|m.2389 | UnnamedSample_HQ_transcript/5594 | Coverage 0.127 too low. | a91d6e27f0e4decc6615216ea7e4f6c9 | 1253 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 253 | 331 | 3.6E-7 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/5594|m.2389 | UnnamedSample_HQ_transcript/5594 | Coverage 0.127 too low. | a91d6e27f0e4decc6615216ea7e4f6c9 | 1253 | Pfam | PF13895 | Immunoglobulin domain | 554 | 628 | 3.7E-7 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/5594|m.2389 | UnnamedSample_HQ_transcript/5594 | Coverage 0.127 too low. | a91d6e27f0e4decc6615216ea7e4f6c9 | 1253 | Pfam | PF00047 | Immunoglobulin domain | 156 | 233 | 4.0E-8 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/5594|m.2389 | UnnamedSample_HQ_transcript/5594 | Coverage 0.127 too low. | a91d6e27f0e4decc6615216ea7e4f6c9 | 1253 | Pfam | PF07686 | Immunoglobulin V-set domain | 27 | 111 | 2.3E-7 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/5594|m.2389 | UnnamedSample_HQ_transcript/5594 | Coverage 0.127 too low. | a91d6e27f0e4decc6615216ea7e4f6c9 | 1253 | Pfam | PF13927 | Immunoglobulin domain | 352 | 428 | 4.0E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/94737|m.21915 | UnnamedSample_HQ_transcript/94737 | Coverage 0.355 too low. | 430445e957e59fd01bdfb8c16de758ca | 287 | Pfam | PF00595 | PDZ domain | 85 | 154 | 1.7E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/103109|m.23003 | UnnamedSample_HQ_transcript/103109 | Coverage 0.950 too low. | 0c22c3d52657c5b0c20d4aa8be5bc7cf | 235 | Pfam | PF01709 | Transcriptional regulator | 53 | 234 | 6.5E-40 | T | 22-09-2020 | IPR002876 | Transcriptional regulator TACO1-like |
| UnnamedSample_HQ_transcript/54236|m.14884 | UnnamedSample_HQ_transcript/54236 | Coverage 0.982 too low. | 1d375cac3d2918c8b9364e39ae4678ff | 677 | Pfam | PF01751 | Toprim domain | 145 | 246 | 2.9E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/54236|m.14884 | UnnamedSample_HQ_transcript/54236 | Coverage 0.982 too low. | 1d375cac3d2918c8b9364e39ae4678ff | 677 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 261 | 404 | 3.5E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/54236|m.14884 | UnnamedSample_HQ_transcript/54236 | Coverage 0.982 too low. | 1d375cac3d2918c8b9364e39ae4678ff | 677 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 406 | 676 | 6.6E-93 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/54236|m.14884 | UnnamedSample_HQ_transcript/54236 | Coverage 0.982 too low. | 1d375cac3d2918c8b9364e39ae4678ff | 677 | Pfam | PF00204 | DNA gyrase B | 1 | 116 | 6.1E-22 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 746 | 834 | 3.0E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 11 | 48 | 7.9E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 237 | 323 | 3.4E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 339 | 421 | 1.2E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 432 | 516 | 1.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 58 | 140 | 6.2E-19 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 619 | 704 | 5.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/11217|m.4227 | UnnamedSample_HQ_transcript/11217 | Coverage 0.276 too low. | 8de5e993e5cc53ac30144e29926285b7 | 837 | Pfam | PF00630 | Filamin/ABP280 repeat | 538 | 610 | 5.2E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25628|m.8379 | UnnamedSample_HQ_transcript/25628 | Coverage 0.571 too low. | bf91fa3bcf59562ea7ebe324483f8463 | 427 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 44 | 174 | 2.2E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25628|m.8379 | UnnamedSample_HQ_transcript/25628 | Coverage 0.571 too low. | bf91fa3bcf59562ea7ebe324483f8463 | 427 | Pfam | PF00098 | Zinc knuckle | 270 | 285 | 3.6E-4 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/25628|m.8379 | UnnamedSample_HQ_transcript/25628 | Coverage 0.571 too low. | bf91fa3bcf59562ea7ebe324483f8463 | 427 | Pfam | PF00098 | Zinc knuckle | 195 | 212 | 5.7E-5 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/39134|m.11667 | UnnamedSample_HQ_transcript/39134 | Coverage 0.841 too low. | 162a33911fdc8c1a6d9b84677880ae0e | 603 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 410 | 573 | 9.3E-61 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF07645 | Calcium-binding EGF domain | 485 | 519 | 5.6E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF07645 | Calcium-binding EGF domain | 537 | 566 | 0.0014 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF02412 | Thrombospondin type 3 repeat | 665 | 700 | 8.4E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF02412 | Thrombospondin type 3 repeat | 786 | 823 | 5.4E-10 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF02412 | Thrombospondin type 3 repeat | 727 | 762 | 1.0E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF02412 | Thrombospondin type 3 repeat | 860 | 893 | 4.0E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF02412 | Thrombospondin type 3 repeat | 825 | 859 | 8.8E-10 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/5400|m.2335 | UnnamedSample_HQ_transcript/5400 | Coverage 0.984 too low. | 4dea63435e9622937080d96f1df8c337 | 1139 | Pfam | PF05735 | Thrombospondin C-terminal region | 913 | 1110 | 1.8E-93 | T | 22-09-2020 | IPR008859 | Thrombospondin, C-terminal |
| UnnamedSample_HQ_transcript/75814|m.18986 | UnnamedSample_HQ_transcript/75814 | Coverage 0.804 too low. | 089a967efe4d51fcf2eac0ad1b675e31 | 438 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.5E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/4153|m.1865 | UnnamedSample_HQ_transcript/4153 | Coverage 0.125 too low. | 22a1963b2803f4fb8f0a09694e81946d | 1319 | Pfam | PF00169 | PH domain | 670 | 768 | 1.8E-9 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/4153|m.1865 | UnnamedSample_HQ_transcript/4153 | Coverage 0.125 too low. | 22a1963b2803f4fb8f0a09694e81946d | 1319 | Pfam | PF00169 | PH domain | 560 | 652 | 1.4E-10 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/4153|m.1865 | UnnamedSample_HQ_transcript/4153 | Coverage 0.125 too low. | 22a1963b2803f4fb8f0a09694e81946d | 1319 | Pfam | PF00784 | MyTH4 domain | 854 | 904 | 1.4E-6 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/4153|m.1865 | UnnamedSample_HQ_transcript/4153 | Coverage 0.125 too low. | 22a1963b2803f4fb8f0a09694e81946d | 1319 | Pfam | PF00784 | MyTH4 domain | 931 | 1009 | 1.6E-20 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/4153|m.1865 | UnnamedSample_HQ_transcript/4153 | Coverage 0.125 too low. | 22a1963b2803f4fb8f0a09694e81946d | 1319 | Pfam | PF00373 | FERM central domain | 1127 | 1257 | 3.2E-15 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/21860|m.7385 | UnnamedSample_HQ_transcript/21860 | Coverage 0.940 too low. | 27ea5f22ad8c816d3f82369f45cbd8d9 | 558 | Pfam | PF00379 | Insect cuticle protein | 121 | 163 | 1.2E-7 | T | 22-09-2020 | IPR000618 | Insect cuticle protein |
| UnnamedSample_HQ_transcript/38302|m.11463 | UnnamedSample_HQ_transcript/38302 | Coverage 0.925 too low. | 27ea5f22ad8c816d3f82369f45cbd8d9 | 558 | Pfam | PF00379 | Insect cuticle protein | 121 | 163 | 1.2E-7 | T | 22-09-2020 | IPR000618 | Insect cuticle protein |
| UnnamedSample_HQ_transcript/34358|m.10564 | UnnamedSample_HQ_transcript/34358 | Coverage 0.930 too low. | 27ea5f22ad8c816d3f82369f45cbd8d9 | 558 | Pfam | PF00379 | Insect cuticle protein | 121 | 163 | 1.2E-7 | T | 22-09-2020 | IPR000618 | Insect cuticle protein |
| UnnamedSample_HQ_transcript/92229|m.21568 | UnnamedSample_HQ_transcript/92229 | Identity 0.935 too low. | a2905d365dc92303258b729b961d4275 | 146 | Pfam | PF00145 | C-5 cytosine-specific DNA methylase | 58 | 129 | 3.7E-16 | T | 22-09-2020 | IPR001525 | C-5 cytosine methyltransferase |
| UnnamedSample_HQ_transcript/113704|m.24263 | UnnamedSample_HQ_transcript/113704 | Identity 0.367 too low. | 30e47f0bfda2bf8d20a3b8255aab82c7 | 238 | Pfam | PF08246 | Cathepsin propeptide inhibitor domain (I29) | 26 | 81 | 6.4E-15 | T | 22-09-2020 | IPR013201 | Cathepsin propeptide inhibitor domain (I29) |
| UnnamedSample_HQ_transcript/113704|m.24263 | UnnamedSample_HQ_transcript/113704 | Identity 0.367 too low. | 30e47f0bfda2bf8d20a3b8255aab82c7 | 238 | Pfam | PF00112 | Papain family cysteine protease | 116 | 218 | 2.3E-12 | T | 22-09-2020 | IPR000668 | Peptidase C1A, papain C-terminal |
| UnnamedSample_HQ_transcript/50794|m.14200 | UnnamedSample_HQ_transcript/50794 | Identity 0.863 too low. | de6a397772756096cfaf13df3c8798a0 | 486 | Pfam | PF07690 | Major Facilitator Superfamily | 49 | 413 | 4.3E-37 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/52057|m.14468 | UnnamedSample_HQ_transcript/52057 | Identity 0.899 too low. | de6a397772756096cfaf13df3c8798a0 | 486 | Pfam | PF07690 | Major Facilitator Superfamily | 49 | 413 | 4.3E-37 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/60883|m.16234 | UnnamedSample_HQ_transcript/60883 | Identity 0.893 too low. | de6a397772756096cfaf13df3c8798a0 | 486 | Pfam | PF07690 | Major Facilitator Superfamily | 49 | 413 | 4.3E-37 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/12183|m.4550 | UnnamedSample_HQ_transcript/12183 | Coverage 0.080 too low. | 5226f4edff2bf0d5cb4eeb50ada9f391 | 1266 | Pfam | PF01302 | CAP-Gly domain | 140 | 204 | 4.4E-19 | T | 22-09-2020 | IPR000938 | CAP Gly-rich domain |
| UnnamedSample_HQ_transcript/84628|m.20437 | UnnamedSample_HQ_transcript/84628 | Coverage 0.880 too low. | c4ef1b7f97d53ecb8474734f1abae59d | 418 | Pfam | PF00505 | HMG (high mobility group) box | 199 | 250 | 1.7E-8 | T | 22-09-2020 | IPR009071 | High mobility group box domain |
| UnnamedSample_HQ_transcript/9215|m.3576 | UnnamedSample_HQ_transcript/9215 | Coverage 0.868 too low. | 9a5f5cc83c5b056d7f828ad127bd62d9 | 1186 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 27 | 264 | 4.8E-69 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/9215|m.3576 | UnnamedSample_HQ_transcript/9215 | Coverage 0.868 too low. | 9a5f5cc83c5b056d7f828ad127bd62d9 | 1186 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 387 | 496 | 9.1E-37 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/9215|m.3576 | UnnamedSample_HQ_transcript/9215 | Coverage 0.868 too low. | 9a5f5cc83c5b056d7f828ad127bd62d9 | 1186 | Pfam | PF14765 | Polyketide synthase dehydratase | 882 | 1078 | 2.6E-11 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/9215|m.3576 | UnnamedSample_HQ_transcript/9215 | Coverage 0.868 too low. | 9a5f5cc83c5b056d7f828ad127bd62d9 | 1186 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 268 | 384 | 4.0E-40 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/9215|m.3576 | UnnamedSample_HQ_transcript/9215 | Coverage 0.868 too low. | 9a5f5cc83c5b056d7f828ad127bd62d9 | 1186 | Pfam | PF00698 | Acyl transferase domain | 516 | 830 | 3.1E-86 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/69477|m.17840 | UnnamedSample_HQ_transcript/69477 | Coverage 0.744 too low. | 45bf4959bfaaba327324f446d8991f94 | 260 | Pfam | PF07002 | Copine | 37 | 254 | 1.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/73071|m.18494 | UnnamedSample_HQ_transcript/73071 | Coverage 0.623 too low. | 45bf4959bfaaba327324f446d8991f94 | 260 | Pfam | PF07002 | Copine | 37 | 254 | 1.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/57896|m.15631 | UnnamedSample_HQ_transcript/57896 | Coverage 0.656 too low. | 45bf4959bfaaba327324f446d8991f94 | 260 | Pfam | PF07002 | Copine | 37 | 254 | 1.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/73035|m.18489 | UnnamedSample_HQ_transcript/73035 | Coverage 0.793 too low. | 45bf4959bfaaba327324f446d8991f94 | 260 | Pfam | PF07002 | Copine | 37 | 254 | 1.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/59621|m.15983 | UnnamedSample_HQ_transcript/59621 | Coverage 0.666 too low. | 45bf4959bfaaba327324f446d8991f94 | 260 | Pfam | PF07002 | Copine | 37 | 254 | 1.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/46814|m.13325 | UnnamedSample_HQ_transcript/46814 | Coverage 0.575 too low. | 45bf4959bfaaba327324f446d8991f94 | 260 | Pfam | PF07002 | Copine | 37 | 254 | 1.2E-87 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/70674|m.18046 | UnnamedSample_HQ_transcript/70674 | Coverage 0.863 too low. | b204ab226c24b37db53bca703e1d59fd | 513 | Pfam | PF00168 | C2 domain | 3 | 98 | 9.2E-22 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/26072|m.8496 | UnnamedSample_HQ_transcript/26072 | Coverage 0.939 too low. | 026a70f42b831ac65f1fda150d9f44fe | 915 | Pfam | PF00567 | Tudor domain | 791 | 871 | 1.2E-10 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/26072|m.8496 | UnnamedSample_HQ_transcript/26072 | Coverage 0.939 too low. | 026a70f42b831ac65f1fda150d9f44fe | 915 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.1E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/26072|m.8496 | UnnamedSample_HQ_transcript/26072 | Coverage 0.939 too low. | 026a70f42b831ac65f1fda150d9f44fe | 915 | Pfam | PF00567 | Tudor domain | 381 | 491 | 6.3E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/15256|m.5482 | UnnamedSample_HQ_transcript/15256 | Identity 0.901 too low. | 026a70f42b831ac65f1fda150d9f44fe | 915 | Pfam | PF00567 | Tudor domain | 791 | 871 | 1.2E-10 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/15256|m.5482 | UnnamedSample_HQ_transcript/15256 | Identity 0.901 too low. | 026a70f42b831ac65f1fda150d9f44fe | 915 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.1E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/15256|m.5482 | UnnamedSample_HQ_transcript/15256 | Identity 0.901 too low. | 026a70f42b831ac65f1fda150d9f44fe | 915 | Pfam | PF00567 | Tudor domain | 381 | 491 | 6.3E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/25740|m.8408 | UnnamedSample_HQ_transcript/25740 | Coverage 0.987 too low. | 7d5af071dfbc6f1439ff22c05d49a524 | 609 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 28 | 108 | 4.0E-7 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/25740|m.8408 | UnnamedSample_HQ_transcript/25740 | Coverage 0.987 too low. | 7d5af071dfbc6f1439ff22c05d49a524 | 609 | Pfam | PF11904 | GPCR-chaperone | 168 | 471 | 4.2E-88 | T | 22-09-2020 | IPR021832 | Ankyrin repeat domain-containing protein 13 |
| UnnamedSample_HQ_transcript/85769|m.20612 | UnnamedSample_HQ_transcript/85769 | Identity 0.576 too low. | bda6c355205063924119a13c2983f4be | 301 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 84 | 124 | 3.3E-8 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/85769|m.20612 | UnnamedSample_HQ_transcript/85769 | Identity 0.576 too low. | bda6c355205063924119a13c2983f4be | 301 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 128 | 167 | 3.0E-14 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/85769|m.20612 | UnnamedSample_HQ_transcript/85769 | Identity 0.576 too low. | bda6c355205063924119a13c2983f4be | 301 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 170 | 213 | 2.0E-9 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/96225|m.22127 | UnnamedSample_HQ_transcript/96225 | Identity 0.510 too low. | bda6c355205063924119a13c2983f4be | 301 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 84 | 124 | 3.3E-8 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/96225|m.22127 | UnnamedSample_HQ_transcript/96225 | Identity 0.510 too low. | bda6c355205063924119a13c2983f4be | 301 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 128 | 167 | 3.0E-14 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/96225|m.22127 | UnnamedSample_HQ_transcript/96225 | Identity 0.510 too low. | bda6c355205063924119a13c2983f4be | 301 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 170 | 213 | 2.0E-9 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/71567|m.18220 | UnnamedSample_HQ_transcript/71567 | Coverage 0.831 too low. | ab08a22402dc18b6511c00b61e4f0134 | 449 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 42 | 102 | 1.0E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/89629|m.21181 | UnnamedSample_HQ_transcript/89629 | Coverage 0.093 too low. | 6d817533112fe281fe17a397e5bd1151 | 420 | Pfam | PF17751 | SKICH domain | 49 | 143 | 1.2E-7 | T | 22-09-2020 | IPR041611 | SKICH domain |
| UnnamedSample_HQ_transcript/19707|m.6789 | UnnamedSample_HQ_transcript/19707 | Coverage 0.956 too low. | 252d9709f42a735e6683069ad483560f | 714 | Pfam | PF01061 | ABC-2 type transporter | 442 | 651 | 2.8E-47 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/19707|m.6789 | UnnamedSample_HQ_transcript/19707 | Coverage 0.956 too low. | 252d9709f42a735e6683069ad483560f | 714 | Pfam | PF19055 | ABC-2 type transporter | 318 | 385 | 3.7E-10 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/19707|m.6789 | UnnamedSample_HQ_transcript/19707 | Coverage 0.956 too low. | 252d9709f42a735e6683069ad483560f | 714 | Pfam | PF00005 | ABC transporter | 135 | 289 | 2.5E-21 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/54816|m.15009 | UnnamedSample_HQ_transcript/54816 | Coverage 0.214 too low. | e5751c54859db7ee6536a54f3267d655 | 377 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 326 | 362 | 2.1E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/96458|m.22160 | UnnamedSample_HQ_transcript/96458 | Coverage 0.954 too low. | 485c33ab91bf9c2b0c6ebcacca650241 | 279 | Pfam | PF10587 | Eukaryotic elongation factor 1 beta central acidic region | 94 | 119 | 1.2E-10 | T | 22-09-2020 | IPR018940 | Elongation factor 1 beta central acidic region, eukaryote |
| UnnamedSample_HQ_transcript/96458|m.22160 | UnnamedSample_HQ_transcript/96458 | Coverage 0.954 too low. | 485c33ab91bf9c2b0c6ebcacca650241 | 279 | Pfam | PF02135 | TAZ zinc finger | 185 | 252 | 2.0E-7 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/101139|m.22767 | UnnamedSample_HQ_transcript/101139 | Coverage 0.987 too low. | c41d9bbb979bbdbbb3c3cedb0d8a0d74 | 287 | Pfam | PF02755 | RPEL repeat | 262 | 283 | 1.7E-7 | T | 22-09-2020 | IPR004018 | RPEL repeat |
| UnnamedSample_HQ_transcript/101139|m.22767 | UnnamedSample_HQ_transcript/101139 | Coverage 0.987 too low. | c41d9bbb979bbdbbb3c3cedb0d8a0d74 | 287 | Pfam | PF02755 | RPEL repeat | 223 | 244 | 2.3E-8 | T | 22-09-2020 | IPR004018 | RPEL repeat |
| UnnamedSample_HQ_transcript/39049|m.11641 | UnnamedSample_HQ_transcript/39049 | Coverage 0.898 too low. | 0abbb15a286a7306bce31658c628c9cb | 762 | Pfam | PF08687 | Apx/Shroom domain ASD2 | 562 | 760 | 7.4E-27 | T | 22-09-2020 | IPR014799 | Apx/Shrm Domain 2 |
| UnnamedSample_HQ_transcript/54315|m.14898 | UnnamedSample_HQ_transcript/54315 | Coverage 0.973 too low. | a1ac7f2d792595ddc1a261ed1be3999d | 481 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 6 | 242 | 6.4E-59 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/119749|m.24826 | UnnamedSample_HQ_transcript/119749 | Coverage 0.937 too low. | b8fb58f552fb2608f47954f482c867ac | 159 | Pfam | PF03178 | CPSF A subunit region | 2 | 108 | 4.8E-26 | T | 22-09-2020 | IPR004871 | Cleavage/polyadenylation specificity factor, A subunit, C-terminal |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 68 | 92 | 1.1E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 102 | 149 | 3.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 263 | 307 | 1.8E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 357 | 396 | 3.3E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 210 | 260 | 2.0E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 152 | 207 | 9.8E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00053 | Laminin EGF domain | 310 | 354 | 2.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF00052 | Laminin B (Domain IV) | 3 | 67 | 2.2E-7 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/1371|m.792 | UnnamedSample_HQ_transcript/1371 | Coverage 0.092 too low. | bb9165b7592996389b2138d09607953b | 1026 | Pfam | PF06009 | Laminin Domain II | 858 | 980 | 1.3E-9 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/57692|m.15590 | UnnamedSample_HQ_transcript/57692 | Coverage 0.343 too low. | 827661b49ee41d383bb81060d8e3e067 | 168 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 12 | 96 | 2.5E-4 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/14785|m.5349 | UnnamedSample_HQ_transcript/14785 | Identity 0.698 too low. | 827661b49ee41d383bb81060d8e3e067 | 168 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 12 | 96 | 2.5E-4 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/34398|m.10576 | UnnamedSample_HQ_transcript/34398 | Coverage 0.704 too low. | 4a7346239f2cdf7f6f64a3b4f92cce6a | 375 | Pfam | PF00781 | Diacylglycerol kinase catalytic domain | 174 | 312 | 2.3E-27 | T | 22-09-2020 | IPR001206 | Diacylglycerol kinase, catalytic domain |
| UnnamedSample_HQ_transcript/35011|m.10722 | UnnamedSample_HQ_transcript/35011 | Coverage 0.076 too low. | 21384a2fce74c14ad8ca58a7071f429c | 350 | Pfam | PF03250 | Tropomodulin | 13 | 152 | 4.5E-55 | T | 22-09-2020 | IPR004934 | Tropomodulin |
| UnnamedSample_HQ_transcript/65754|m.17155 | UnnamedSample_HQ_transcript/65754 | Coverage 0.928 too low. | 7219f3cd6ab9575c79f9eb009a6de70a | 421 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 108 | 172 | 8.5E-18 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/65754|m.17155 | UnnamedSample_HQ_transcript/65754 | Coverage 0.928 too low. | 7219f3cd6ab9575c79f9eb009a6de70a | 421 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 11 | 72 | 5.9E-11 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/12815|m.4761 | UnnamedSample_HQ_transcript/12815 | Coverage 0.986 too low. | 4263edf43d43b2cebfe9e3af96c9fdb9 | 1151 | Pfam | PF08699 | Argonaute linker 1 domain | 471 | 525 | 4.3E-9 | T | 22-09-2020 | IPR014811 | Argonaute, linker 1 domain |
| UnnamedSample_HQ_transcript/12815|m.4761 | UnnamedSample_HQ_transcript/12815 | Coverage 0.986 too low. | 4263edf43d43b2cebfe9e3af96c9fdb9 | 1151 | Pfam | PF02170 | PAZ domain | 559 | 659 | 1.2E-9 | T | 22-09-2020 | IPR003100 | PAZ domain |
| UnnamedSample_HQ_transcript/12815|m.4761 | UnnamedSample_HQ_transcript/12815 | Coverage 0.986 too low. | 4263edf43d43b2cebfe9e3af96c9fdb9 | 1151 | Pfam | PF02171 | Piwi domain | 806 | 1111 | 2.4E-85 | T | 22-09-2020 | IPR003165 | Piwi domain |
| UnnamedSample_HQ_transcript/12815|m.4761 | UnnamedSample_HQ_transcript/12815 | Coverage 0.986 too low. | 4263edf43d43b2cebfe9e3af96c9fdb9 | 1151 | Pfam | PF16486 | N-terminal domain of argonaute | 332 | 444 | 8.9E-10 | T | 22-09-2020 | IPR032474 | Protein argonaute, N-terminal |
| UnnamedSample_HQ_transcript/11882|m.4457 | UnnamedSample_HQ_transcript/11882 | Identity 0.922 too low. | 38c46773cfa55e31a0094a2e92712ad2 | 895 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 659 | 862 | 7.9E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/11882|m.4457 | UnnamedSample_HQ_transcript/11882 | Identity 0.922 too low. | 38c46773cfa55e31a0094a2e92712ad2 | 895 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 222 | 589 | 6.9E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11882|m.4457 | UnnamedSample_HQ_transcript/11882 | Identity 0.922 too low. | 38c46773cfa55e31a0094a2e92712ad2 | 895 | Pfam | PF00122 | E1-E2 ATPase | 4 | 204 | 2.6E-52 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/10173|m.3884 | UnnamedSample_HQ_transcript/10173 | Coverage 0.050 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 598 | 830 | 1.4E-83 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/10173|m.3884 | UnnamedSample_HQ_transcript/10173 | Coverage 0.050 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF01590 | GAF domain | 308 | 491 | 1.5E-12 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/10173|m.3884 | UnnamedSample_HQ_transcript/10173 | Coverage 0.050 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF01590 | GAF domain | 124 | 274 | 1.1E-17 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/12739|m.4738 | UnnamedSample_HQ_transcript/12739 | Coverage 0.053 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 598 | 830 | 1.4E-83 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/12739|m.4738 | UnnamedSample_HQ_transcript/12739 | Coverage 0.053 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF01590 | GAF domain | 308 | 491 | 1.5E-12 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/12739|m.4738 | UnnamedSample_HQ_transcript/12739 | Coverage 0.053 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF01590 | GAF domain | 124 | 274 | 1.1E-17 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/9729|m.3739 | UnnamedSample_HQ_transcript/9729 | Coverage 0.040 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 598 | 830 | 1.4E-83 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/9729|m.3739 | UnnamedSample_HQ_transcript/9729 | Coverage 0.040 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF01590 | GAF domain | 308 | 491 | 1.5E-12 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/9729|m.3739 | UnnamedSample_HQ_transcript/9729 | Coverage 0.040 too low. | 1d0fdcb9231afed0d5edbf553c4b8b42 | 1001 | Pfam | PF01590 | GAF domain | 124 | 274 | 1.1E-17 | T | 22-09-2020 | IPR003018 | GAF domain |
| UnnamedSample_HQ_transcript/30602|m.9615 | UnnamedSample_HQ_transcript/30602 | Coverage 0.946 too low. | d243220b3bdee91e7ebf3d6b43d1573f | 920 | Pfam | PF00063 | Myosin head (motor domain) | 17 | 694 | 1.6E-285 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/108407|m.23630 | UnnamedSample_HQ_transcript/108407 | Identity 0.894 too low. | 7e1008b1ff5b2659c68f5b374cab6b49 | 309 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 12 | 51 | 1.3E-11 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/115026|m.24400 | UnnamedSample_HQ_transcript/115026 | Coverage 0.987 too low. | c42d50ce1dac4ce946b75d6e17fe190b | 150 | Pfam | PF00155 | Aminotransferase class I and II | 23 | 116 | 1.1E-6 | T | 22-09-2020 | IPR004839 | Aminotransferase, class I/classII |
| UnnamedSample_HQ_transcript/5079|m.2227 | UnnamedSample_HQ_transcript/5079 | Coverage 0.183 too low. | a3535b35d11dd45194cd44df096acad2 | 528 | Pfam | PF00439 | Bromodomain | 166 | 246 | 1.6E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/87192|m.20820 | UnnamedSample_HQ_transcript/87192 | Identity 0.841 too low. | 1578283b4dd3437b6fc3a66e642403d7 | 321 | Pfam | PF00650 | CRAL/TRIO domain | 128 | 280 | 4.2E-36 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/24364|m.8037 | UnnamedSample_HQ_transcript/24364 | Coverage 0.984 too low. | 7db85f8ecea4afd4c2b51b613c2b775f | 959 | Pfam | PF13086 | AAA domain | 831 | 926 | 3.3E-11 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/39484|m.11739 | UnnamedSample_HQ_transcript/39484 | Coverage 0.975 too low. | 0b7fd9a2207f45fc71c611e8d1ea5426 | 642 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 91 | 639 | 3.7E-192 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/56113|m.15261 | UnnamedSample_HQ_transcript/56113 | Coverage 0.659 too low. | 19ca2e591136676a0e4403f5afdd4fa8 | 357 | Pfam | PF00651 | BTB/POZ domain | 184 | 286 | 2.7E-27 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/56113|m.15261 | UnnamedSample_HQ_transcript/56113 | Coverage 0.659 too low. | 19ca2e591136676a0e4403f5afdd4fa8 | 357 | Pfam | PF00917 | MATH domain | 54 | 154 | 2.7E-6 | T | 22-09-2020 | IPR002083 | MATH/TRAF domain |
| UnnamedSample_HQ_transcript/84792|m.20460 | UnnamedSample_HQ_transcript/84792 | Coverage 0.846 too low. | 10b68345b320a676a1b04cc9d79e94a7 | 252 | Pfam | PF00651 | BTB/POZ domain | 22 | 119 | 4.6E-26 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/38280|m.11460 | UnnamedSample_HQ_transcript/38280 | Coverage 0.333 too low. | a2e91db1b124a03e1fe0cc31604465e0 | 287 | Pfam | PF00135 | Carboxylesterase family | 5 | 276 | 2.4E-73 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/59831|m.16025 | UnnamedSample_HQ_transcript/59831 | Coverage 0.270 too low. | c9718cd4d0e4aeac169fac53b0aa0eb3 | 480 | Pfam | PF07727 | Reverse transcriptase (RNA-dependent DNA polymerase) | 6 | 240 | 2.2E-44 | T | 22-09-2020 | IPR013103 | Reverse transcriptase, RNA-dependent DNA polymerase |
| UnnamedSample_HQ_transcript/35111|m.10737 | UnnamedSample_HQ_transcript/35111 | Coverage 0.632 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 323 | 454 | 1.0E-8 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/35111|m.10737 | UnnamedSample_HQ_transcript/35111 | Coverage 0.632 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03351 | DOMON domain | 5 | 104 | 1.4E-8 | T | 22-09-2020 | IPR005018 | DOMON domain |
| UnnamedSample_HQ_transcript/35675|m.10854 | UnnamedSample_HQ_transcript/35675 | Coverage 0.596 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 323 | 454 | 1.0E-8 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/35675|m.10854 | UnnamedSample_HQ_transcript/35675 | Coverage 0.596 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03351 | DOMON domain | 5 | 104 | 1.4E-8 | T | 22-09-2020 | IPR005018 | DOMON domain |
| UnnamedSample_HQ_transcript/38929|m.11610 | UnnamedSample_HQ_transcript/38929 | Coverage 0.620 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 323 | 454 | 1.0E-8 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/38929|m.11610 | UnnamedSample_HQ_transcript/38929 | Coverage 0.620 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03351 | DOMON domain | 5 | 104 | 1.4E-8 | T | 22-09-2020 | IPR005018 | DOMON domain |
| UnnamedSample_HQ_transcript/43885|m.12687 | UnnamedSample_HQ_transcript/43885 | Coverage 0.658 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03188 | Eukaryotic cytochrome b561 | 323 | 454 | 1.0E-8 | T | 22-09-2020 | IPR006593 | Cytochrome b561/ferric reductase transmembrane |
| UnnamedSample_HQ_transcript/43885|m.12687 | UnnamedSample_HQ_transcript/43885 | Coverage 0.658 too low. | 676913a986acdc76c724810e0b2b6b9e | 559 | Pfam | PF03351 | DOMON domain | 5 | 104 | 1.4E-8 | T | 22-09-2020 | IPR005018 | DOMON domain |
| UnnamedSample_HQ_transcript/49893|m.14000 | UnnamedSample_HQ_transcript/49893 | Coverage 0.739 too low. | c18ef6f851b716296c43cb2624916bb1 | 442 | Pfam | PF07690 | Major Facilitator Superfamily | 21 | 357 | 2.6E-27 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/55598|m.15154 | UnnamedSample_HQ_transcript/55598 | Coverage 0.729 too low. | c18ef6f851b716296c43cb2624916bb1 | 442 | Pfam | PF07690 | Major Facilitator Superfamily | 21 | 357 | 2.6E-27 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/60750|m.16208 | UnnamedSample_HQ_transcript/60750 | Coverage 0.941 too low. | 35b48717ee386808a45474f531670931 | 589 | Pfam | PF00096 | Zinc finger, C2H2 type | 481 | 503 | 3.2E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/60750|m.16208 | UnnamedSample_HQ_transcript/60750 | Coverage 0.941 too low. | 35b48717ee386808a45474f531670931 | 589 | Pfam | PF00096 | Zinc finger, C2H2 type | 565 | 585 | 0.0043 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/60750|m.16208 | UnnamedSample_HQ_transcript/60750 | Coverage 0.941 too low. | 35b48717ee386808a45474f531670931 | 589 | Pfam | PF00096 | Zinc finger, C2H2 type | 509 | 531 | 0.0018 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/60750|m.16208 | UnnamedSample_HQ_transcript/60750 | Coverage 0.941 too low. | 35b48717ee386808a45474f531670931 | 589 | Pfam | PF12874 | Zinc-finger of C2H2 type | 425 | 443 | 0.0025 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/61034|m.16265 | UnnamedSample_HQ_transcript/61034 | Coverage 0.820 too low. | 5cd880ed0cf4ddde824a8e3397bb4ff9 | 636 | Pfam | PF01044 | Vinculin family | 15 | 262 | 1.2E-38 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/95582|m.22038 | UnnamedSample_HQ_transcript/95582 | Coverage 0.980 too low. | 9510418f462c225fdd901bcaf36a4593 | 250 | Pfam | PF00227 | Proteasome subunit | 39 | 226 | 5.4E-33 | T | 22-09-2020 | IPR001353 | Proteasome, subunit alpha/beta |
| UnnamedSample_HQ_transcript/82926|m.20181 | UnnamedSample_HQ_transcript/82926 | Coverage 0.960 too low. | 201703b21c0ea4a41e5d0c488fbd646b | 457 | Pfam | PF12874 | Zinc-finger of C2H2 type | 133 | 151 | 9.5E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25922|m.8455 | UnnamedSample_HQ_transcript/25922 | Identity 0.760 too low. | a1d48890b9605599fd035a2345532afb | 911 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 792 | 906 | 1.3E-13 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/25922|m.8455 | UnnamedSample_HQ_transcript/25922 | Identity 0.760 too low. | a1d48890b9605599fd035a2345532afb | 911 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 186 | 752 | 3.3E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/25922|m.8455 | UnnamedSample_HQ_transcript/25922 | Identity 0.760 too low. | a1d48890b9605599fd035a2345532afb | 911 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 21 | 102 | 2.8E-15 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/17415|m.6126 | UnnamedSample_HQ_transcript/17415 | Coverage 0.990 too low. | 1d5da9ee6f250edae14f470c2f278e3e | 869 | Pfam | PF00069 | Protein kinase domain | 41 | 291 | 7.2E-77 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/24698|m.8132 | UnnamedSample_HQ_transcript/24698 | Identity 0.946 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF00790 | VHS domain | 7 | 138 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/24698|m.8132 | UnnamedSample_HQ_transcript/24698 | Identity 0.946 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 390 | 482 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/24698|m.8132 | UnnamedSample_HQ_transcript/24698 | Identity 0.946 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF01363 | FYVE zinc finger | 163 | 219 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/24833|m.8176 | UnnamedSample_HQ_transcript/24833 | Identity 0.950 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF00790 | VHS domain | 7 | 138 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/24833|m.8176 | UnnamedSample_HQ_transcript/24833 | Identity 0.950 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 390 | 482 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/24833|m.8176 | UnnamedSample_HQ_transcript/24833 | Identity 0.950 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF01363 | FYVE zinc finger | 163 | 219 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/20759|m.7080 | UnnamedSample_HQ_transcript/20759 | Identity 0.949 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF00790 | VHS domain | 7 | 138 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/20759|m.7080 | UnnamedSample_HQ_transcript/20759 | Identity 0.949 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 390 | 482 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/20759|m.7080 | UnnamedSample_HQ_transcript/20759 | Identity 0.949 too low. | db05f1dd29eaf97430227ba42b99791b | 822 | Pfam | PF01363 | FYVE zinc finger | 163 | 219 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/58585|m.15774 | UnnamedSample_HQ_transcript/58585 | Coverage 0.968 too low. | 3fb97b42d4a114ee22e2a9852303bbd1 | 659 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 1 | 61 | 3.3E-12 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/58585|m.15774 | UnnamedSample_HQ_transcript/58585 | Coverage 0.968 too low. | 3fb97b42d4a114ee22e2a9852303bbd1 | 659 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 63 | 537 | 1.1E-129 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/35135|m.10739 | UnnamedSample_HQ_transcript/35135 | Identity 0.831 too low. | a57cdf6cb83bafe9b0ded40c71638495 | 679 | Pfam | PF02837 | Glycosyl hydrolases family 2, sugar binding domain | 60 | 237 | 2.5E-27 | T | 22-09-2020 | IPR006104 | Glycosyl hydrolases family 2, sugar binding domain |
| UnnamedSample_HQ_transcript/35135|m.10739 | UnnamedSample_HQ_transcript/35135 | Identity 0.831 too low. | a57cdf6cb83bafe9b0ded40c71638495 | 679 | Pfam | PF00703 | Glycosyl hydrolases family 2 | 239 | 351 | 4.8E-7 | T | 22-09-2020 | IPR006102 | Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich |
| UnnamedSample_HQ_transcript/35135|m.10739 | UnnamedSample_HQ_transcript/35135 | Identity 0.831 too low. | a57cdf6cb83bafe9b0ded40c71638495 | 679 | Pfam | PF02836 | Glycosyl hydrolases family 2, TIM barrel domain | 357 | 651 | 1.1E-75 | T | 22-09-2020 | IPR006103 | Glycoside hydrolase family 2, catalytic domain |
| UnnamedSample_HQ_transcript/74453|m.18734 | UnnamedSample_HQ_transcript/74453 | Coverage 0.886 too low. | bdcb2d9270197d6da8349a0751f30ee1 | 456 | Pfam | PF00083 | Sugar (and other) transporter | 47 | 450 | 1.4E-50 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||